statistical adjustment of BP values. Analyses were based on persons aged 25-64 in each country. Sex-and age-adjusted mean systolic/diastolic BPs were 122/80, 119/71 and 120/73 in Mexicans, immigrant MAs and US-born MAs, respectively. The prevalences of hypertension (BPX140/90 or treatment) were 33, 17 and 22%. Hypertension control rates were 3.7, 32.1 and 37.9%, in the same groups. Awareness and treatment rates were 25 and 13% in Mexico and 54 and 46% among MAs in the United States, respectively. Hypertension appears to be more common in Mexico than among Mexican immigrants to the United States. Despite relatively low access to health insurance in the United States, hypertension control increased over the course of this migration.
Introduction
Migration into the United States from Latin America has been accelerating over the past decade, creating new challenges for public health surveillance programs. Although it remains the leading cause of death, the cardiovascular health experience of the Spanish-speaking populations in the United States has not yet been well defined. Vital statistics and other national cohort data suggest lower cardiovascular disease (CVD) risk, although local epidemiological studies in Texas demonstrate substantially higher incidence and mortality. 1 Overall data resources for Mexican Americans (MAs) have improved greatly in the past several years with both local surveys and the extensive oversampling taking place in National Health and Nutrition Examination Survey (NHANES). [2] [3] [4] Comparable surveys with large samples are now being conducted in Mexico as well. 5, 6 Comparisons across the border based on these national probability surveys could help elucidate the complex health transition taking place in this migrant population and suggest ways to improve CVD control by learning the lessons of success.
Hypertension is the most common risk factor for CVD and occurs at a relatively high frequency in all human populations. 7 While evolving lifestyle patterns in modern societies have resulted in modest variation in prevalence, the validity of international comparisons has been severely limited because of non-comparable survey methods. 8, 9 Accurate information on prevalence, control rates and secular trends is also an essential component of a public health strategy to reduce the burden from CVD within a specific country. [10] [11] [12] [13] [14] [15] In recent years, the adoption of standard sampling and measurement procedures has greatly improved our ability to assess trends in prevalence and progress towards treatment and control. 9 We therefore took advantage of the large existing survey data from Mexico and the United States to compare directly patterns of hypertension.
Materials and methods

Data sources
Mexico: National Health Survey (ENSA 2000) . The Encuesta Nacional de Salud 2000 (ENSA 2000) was conducted by the National Institute of Public Health during September 1999 and March 2000. It is a nationally representative cross-sectional sample of the Mexican population. A multi-stage probability sample method was used to select 47 040 households in all 32 states of Mexico, of which 45 756 agreed to participate, resulting in a 97% participation rate. Briefly, geographical characteristics were obtained by region and state from the National Institute of Geography and Informatics. Households were selected and the head of the household chosen as the main informant. Three people were selected in each household, an adult (over 20 years of age), an adolescent (between 10 and 19 years of age) and a child (o10 years of age). Precisely, the sampling process followed the following steps: (1) random selection of 14 counties in each of the 32 states with probability proportional to the number of households; (2) five Á rea Geoestadística Básica (AGEB) (similar to census track) were selected by county with probability proportional to the size (number of people); (3) three blocks per AGEB with equal probability were selected; (4) seven households per block were selected with equal probability and (5) one individual from each age group was chosen with equal probability. A structured questionnaire was used to obtain socio-demographic data, family history, clinical symptoms and medical treatment for various chronic diseases. Blood pressure (BP) was measured twice during a home visit. The first reading was carried out after at least 5 min of rest in the seated position. The same trained nurse took both measures within 5 min from each other on the subjects' right arm using a mercury sphygmomanometer (TXJ-10; ADEX Products, Mexico City, Mexico). The first Korotkoff sound marked the systolic BP (SBP) and the disappearance of sound was taken as the diastolic BP (DBP). Sampling weights were provided for each enrollee to account for the multi-stage design and non-response. Data tapes were prepared by the National Center for Health Surveys at the National Institute of Public Health and made available to the investigators. Initial examination of the data files indicated a small number of implausible or incomplete records. The total sample included 49 294 adults over the age of 20, of whom 33 840 were between 25 and 64 and had complete gender information. The final analytic sample included 31 329 individuals, aged 25-64 years old. Participants with SBP over 300 or below 50 and DBP 4300 or missing (N ¼ 1183), BMI (body mass index) o12 or 460 (N ¼ 560), pregnant women (N ¼ 768) were excluded from the analyses.
Participants were asked the following two questions about a medical history of hypertension and current treatment status: Ha tenido tratamiento médico para controlar su presion alta? Actualmente tome algú n medicamento para controlar su presion alta? viz., Have you ever been treated by a doctor to control your BP? Are you currently taking medication to control your high BP? Medication use was verified by the examining physician and by asking the participant to show their medication. About 90% of those who said they were in hypertension medication showed it to the examiner.
United States: NHANES. The recurrent NHANES draw a random population sample from the United States with over-sampling of minority groups and the elderly. 16 We accessed the public-use tapes for survey years 1999-2004. 16 BP measurement was measured four times in the right arm in the sitting position by trained personnel using a standard mercury device. Anti-hypertensive medication use was documented by a positive response to the question 'Because of {your/SP's} (high blood pressure/hypertension), {have you/has s/he} ever been told to y take prescribed medicine?' Ethnicity/Race was based on the questions: 'Please give me the number of the group that represents {your/SP's} Hispanic origin or ancestry. Please select one or more of these categories,' and 'What race {do you/ does SP} consider {yourself/himself/herself} to be? Please select 1 or more of these categories. ' Age adjustment was accomplished by the direct method using 5-year age groups, where the 2000 Mexican census provided the base population. The second BP determination in each study was used for all the analyses.
Assessment of comparability of BP measurement
As is well recognized, survey methodology can lead to systematic variation in mean levels of BP based on the device employed, number of readings obtained, training of observers and so on. 8, 17 In the absence of direct standardization statistical assessment provides a first-order measure of comparability of survey procedures. In preliminary analyses we examined the age-and gender-specific trends in BP in the Mexican and US surveys. We first examined the age groups under the age of 50, where any differential treatment effect in the two settings would be minimized, and focused on SBP since it can be measured with greater precision. For the resulting six 5-year gender-specific groups the mean difference in SBP, Mexico-US, was 3.3 mm Hg. Under the assumption of equivalent underlying distributions of BP in the two populations, these results indicated that similar measurement technique had been employed. For DBP, on the other hand, a fixed difference of 7.3 mm Hg was observed for each age-gender group. Given the large body of evidence suggesting a consistent cross-cultural correlation in SBP and DBP, we assumed that differential technique was in fact the most likely cause of this consistent difference. In subsequent analyses therefore, to obtain comparable estimates of hypertension prevalence, we adjusted the DBP values for each participant in the Mexican survey by subtracting 7 mm Hg from each DBP measurement. Other regression-based methods of adjustment were considered. In particular, we first estimated the association between DBP and SBP among MAs aged 20-50 in the NHANES survey and then applied the resulting regression coefficients to the ENSA 2000 data. Precisely, we fit sex-specific regression models of DBP on SBP and recorded the parameter estimates. We then applied these parameter estimates to the ENSA 2000 data. Only results corresponding to the first adjustment approach are presented since the other methods did not result in different estimates.
Case definitions 'Hypertension' was defined as SBPX140 or DBPX90 mm Hg or current use of anti-hypertensive medication. Among persons with a history of physician-diagnosed hypertension whose BP was currently o140 and 90 who did not report use of anti-hypertensive medications, it was assumed that they did not have established hypertension and they were not counted as cases. 'Treatment' was defined as current use of anti-hypertensive medications in both surveys, based on the responses described above, 'control' was defined as a BP o140 and 90 mm Hg among medicated hypertensive individuals. The 'control rate' (or, more precisely, the 'proportion controlled') was calculated as the number of treated hypertensive individuals with BPo140/90 mm Hg divided by the total number of hypertensive individuals. 'Control in treated hypertensive' was defined as the number of controlled hypertensive individuals divided by the number of treated hypertensive individuals. Non-pharmacological therapies have begun to receive greater attention and some individuals may have controlled their elevated BP without drugs; we had inconsistent information in these samples to incorporate those interventions into the analyses.
Case definitions for hypertension vary among countries, complicating standardized comparisons. Given access to the original data files for these surveys we were able to choose common cut points for BP definitions of case status. However, a medical history of hypertension and current treatment must also be used to identify hypertensive individuals. If the threshold for treatment varies among practitioners in the two countries then case definitions by this criterion in our samples may vary. This problem in particular complicates the use of the 160/95 threshold since US guidelines have recommended treatment in the general population at 140/90 for many years, and now include 130 systolic in subgroups, like diabetics. 18 Using the definition of a BPX160/96 or treatment would thereby include many persons whose BP never exceeded that level before treatment. These individuals would therefore be counted among those participants whose BP was controlled below 160/95, thereby falsely elevating the estimation of successful treatment. For this reason, in addition to the rapid evolution towards an international standard of 140/90, including Mexico, we have used that threshold as the focus of our analyses.
Statistical analyses
Participants were identified on the basis of the categories defined above. First, all participants were divided into hypertensive individuals vs normotensives. Among the hypertensive individuals it was determined whether they were previously aware of the condition, and whether they were on current treatment. Control status was defined among treated hypertensive cases based on whether the measured BP was o140/90, or o160/95 mm Hg.
Age adjustment was accomplished by the direct method using 5-year age groups determined from the 2000 Mexican census. Sample weights provided for each survey were used to generate the summary tables of prevalence, which therefore represent true national population estimates. Standard errors of the estimated parameters were computed using the statistical package SUDAAN to account for the multi-stage sampling design and sampling weights in both surveys.
Results
Individuals from the two national surveys comprised a total combined analytic sample of 33 024 people, 31 329 of whom were part of ENSA 2000 and 1695 identified themselves as MA in the 1999-2004 NHANES survey. The original sample sizes along with subsequent exclusions are depicted in Figure 1 .
Descriptive characteristics of the participants in ENSA 2000 and the MAs in NHANES are presented in Table 1 . Obesity prevalences were higher among MAs born in the United States (41%) compared to those born in Mexico (32%) and to those surveyed in Mexico (27%). Diabetes is almost twice as high in MAs compared to residents of Mexico. On the contrary, smoking was much less common among MAs than in Mexico. There is evidence of a modest selective migration of persons with lower educational attainment, and this could mediate in part the smoking effect since a positive gradient is observed between smoking and education.
Mean systolic BPs were very similar across all of the sampled groups (Table 2; Figure 2 ). Unadjusted diastolic BPs were consistently higher in Mexico, however, as noted earlier (Figure 3) . Glucose levels were similar in all three groups, except in the two oldest age groups, in which residents of Mexico experience the highest levels, followed by US-born MAs. Sex-adjusted age-specific prevalences of hypertension rose to a maximum of 55% among the oldest participants in Mexico (Table 3 ; Figure 4 ). Hypertension prevelances in the United States were higher among US-born Mexicans than those born in Mexico, except in the youngest and oldest age groups. Tobacco use is more prevalent in Mexico for all ages and no discernible age trend is observed in any of the three groups. Obesity, on the other hand, appears to increase with age in Mexico and among MAs until the age of 54 when a slight decline is observed among those aged 55-64. Age-specific prevalences of diabetes are higher among US residents compared to Mexico, with US-born MAs aged 55-64 experiencing the highest rates. Sex-and age-adjusted prevalence rates of hypertension were higher in Mexico (33.3%) than among foreign-born (17.3%) and US-born (22.4%) MAs in the United States (Table 4) . Age-adjusted estimates of hypertension were highly influenced by the systematically larger values of DBP recorded in ENSA 2000, as illustrated by the decrease on the prevalences after the suggested statistical adjustment (Figure 4) . Adjustments, described in the 'Materials and methods', were carried out by subtracting 7 mm Hg units from each DBP in ENSA 2000.
Education level-specific, age-and sex-adjusted hypertension prevalence was compared across surveys. The highest prevalence was observed among the least educated (less than high school) in Mexico MAs born in the United States were significantly more likely to be aware of the diagnosis of hypertension and under treatment than were the migrants or persons residing in Mexico (Table 4) . The proportion of those sampled whose BP was actually controlled on medication, on the other hand, was substantially better among MAs. As expected, adjustment of DBP values in ENSA 2000 yielded lower prevalence of hypertension and higher awareness and control rates in Mexico. Although hypertension prevalence after adjustment (18%) differs by a smaller amount from the corresponding estimate among MAs (19%), a sizeable gap between the control rates is persistent (13 and 32% in Mexico and among MAs, respectively).
Discussion
To our knowledge, this article represents the first attempt to compare directly representative population data on chronic disease risk factors among Mexicans and MAs. Hypertension was more common in Mexico than in either of the migrant groups, while progress in treatment and control was considerably less advanced in Mexico. On the contrary, diabetes prevalence was substantially lower in Mexico, although it has been increasing over the past decade. [19] [20] [21] As is well known, mortality rates from all forms of CVD are declining sharply in the United States, as a combined result of risk factor control and improved medical care of patients with established disease. Hospital admissions data from Mexico suggest that the rates of coronary heart disease may have peaked and started to decline. It will be important to monitor trends in risk factors and CVD events in both countries to assure that the rapid socio-demographic transitions taking place improve cardiovascular health.
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The large-scale migration to the United States from Mexico presents a series of important challenges as well as opportunities for public health in both countries. Although the subject of an on-going debate, the weight of the evidence suggests that immigrants to the United States from Mexico experience a lower burden of several chronic diseases, including CVD and cancer. 23, 24 This relative advantage appears to wane with longer residence in the United States. An anomalous feature of the health status of MAs has also been the low rate of cigarette smoking, and the associated positive gradient with socio-economic status, a finding reproduced within Mexico. 25 On the other hand, as is well recognized, persons of Mexican descent in the United States have experienced rapid increases in obesity and diabetes, [26] [27] [28] [29] [30] [31] [32] [33] [34] a finding strikingly documented in this article.
Socio-economic indicators are dissimilar in Mexico and the United States and their impact on health could be quite different. In order to address the potential effect of socio economical status (SES) on hypertension and obesity, an education-stratified analysis of these data was conducted. In contrast to the typical negative association between SES and hypertension reported in developed countries, a U-shaped relationship in Mexico, a slightly inverse U-shaped association among foreign-born and a negative association among US-born MAs was observed. However, a combined analysis of MAs in the United States exhibited an inverted U-shaped relationship (19.3, 21.7, 17 .8% for less than HS, completed HS and more than HS, respectively). Obesity prevalence and education exhibited an inverse U-shaped relationship in Mexico among MAs, which is in concordance with the previously observed phenomenon of weight loss later in life. 35, 36 The non-linear association between SES (income distribution) and hypertension in developing countries, elevated levels for low as well as high-SES individuals, has been previously reported. 37 As previously noted, comparative studies of hypertension are constrained by the lack of standardization of survey methodology. Previous national surveys from Mexico have been subjected to direct comparison to US data and no conclusions can be offered about relative prevalences, although it is apparent that treatment and control has been lower in Mexico. The analyses presented here are limited by the need to make statistical adjustment of diastolic BP and we acknowledge that the resulting estimates can only be considered approximate. Despite this limitation, a consistent pattern emerges. Age-specific BPs are very similar among migrants to the United States and those who remained in Mexico. Age-adjusted prevalences were higher in Mexico than in the United States. However, after adjustment of DBP, the prevalence estimates between Mexico and MAs were less dissimilar. Residents of Mexico experience higher prevalence of hypertension than both US-born and foreign-born MAs.
Although increasingly aggressive guidelines have been adopted by professional organizations and Adjusted by subtracting the average DBP difference between Mexico and the United States (7 mm Hg) from each DBP measurement.
Hypertension among Mexican descendents S Barquera et al government agencies in virtually all countries over the past several years, hypertension control ranges between 5 and 30% in most developed countries. [10] [11] [12] [13] 15, 18, [38] [39] [40] [41] In resource-poor settings, on the other hand, success of medical therapy is often even more limited. 42 A sustained effort has been made over the past decade in Mexico to increase awareness of the importance of diagnosis and treatment of hypertension, and large segments of the population have access to affordable health care. Unfortunately, particularly for men, these efforts have only achieved limited success. In this large, representative sample of adults aged 25-64 only, 3.7% of the hypertensive individuals were found to be currently taking anti-hypertensive medication and have BPs below goal. In the United States, both the native and foreign-born MA participants were more likely to have achieved control, they were the less likely to be adequately treated when compared to US whites and blacks. Unfortunately, the complement of data available in these surveys does not provide sufficient detail to explain why treatment is more successful in the United States. MAs, as is well recognized, have a less consistent source of a regular source of care in the United States than do other groups.
Migrant studies, for example the 'Ni-Hon-San' and the 'Irish Brothers' studies, have been used to investigate changes in health status among other historical migrant groups. 43, 44 Immigrants born in Ireland, Scotland, East Africa and West Africa experience higher mortality from all causes than the England and Wales national average. 45 Stroke and hypertension rates among foreign-born Irish and Scottish immigrants was also higher than the national average, whereas all cause mortality was lower among Caribbean immigrants. 46 In Sweden, elderly foreign-born residents have a worse cardiovascular risk profile than Swedish-born person, 47 and Southern European, Eastern European and Finish immigrants exhibited increased risk of poor health. All cause mortality in Sweden was not associated with nativity. 48 In general, migrant groups have arrived in the United States with lower average CVD risk in comparison to the native US population and experienced a subsequent increase. [49] [50] [51] [52] [53] Among Hispanics, in particular MAs, nativity and acculturation are associated with chronic diseases and CVD risk factors. [54] [55] [56] [57] On the basis of our analysis of vital statistics age-adjusted, heart disease mortality rates (2000 census population of Mexico used as reference) in the year 2000 in Mexico (367 per 100 000 population) are currently less than those found in the United States as a whole (468 per 100 000 population), and in MAs (400 per 100 000 population), while stroke rates are higher in Mexico. A more detailed analysis of the full range of CVD risk factors would be required to assess the underlying causes of this differential. We have shown in this analysis, however, that uncontrolled hypertension is more frequent in Mexico which could partially explain the difference in stroke rates. Rapidly rising rates of diabetes are posing a series threat on both sides of the border. In the most recent year of vital statistics data, in fact, diabetes has emerged as the leading cause of death in Mexico. Since coding practices often influence whether diabetes is designated as the underlying or contributing cause, cross-country comparison of this outcome is particularly difficult. Nonetheless, consistent monitoring of trends in these populations will be important to keep abreast of the rapidly changing public health challenges.
Important potential limitations should be taken into account in the interpretation of the data presented in this article. First and foremost is the degree to which the measurements of BP are comparable. While similar methods were used, we recognize that rigorous training is required to bring standardized procedures into the field. The statistical procedures we used provide an approximation to standardization, however further attention to this aspect of the surveys should be implemented in future studies to enhance comparisons. The age-related difference in the slope of BP with age in the two studies is unusual and cannot easily be explained by survey methods, further underscoring the need for caution in the interpretation of these data. Other measurements, such as BMI and diabetes, are less likely to be subject to bias. Limitations such as these are intrinsic to large epidemiological studies, even among those conducted using similar methodology, but at different time periods. This may be due to improvements/ changes in technology and survey methods, as well as available resources to conduct such studies. For instance, in the United States, there are known differences between the different waves of the NHAHES that preclude a direct comparison. For instance, a decline of over 10 mm Hg in age-adjusted average SBP is seen between NHANES I and III (from 132 to 121 mm Hg) and a 15% decrease in the prevalence in hypertension (from 40 to 25%), change not entirely attributable to decreases in BP and potentially due to methodological shifts over time. Age-adjusted mean SBP increased from NHANES III to NHANES 1999-2000 (from 121 to 124 mm Hg). The inherent difficulties in comparing sequential surveys are discussed by Primatesta et al. 13, 58 when comparing various waves of the Health Survey for England.
In conclusion, we have compared large, nationally representative surveys of hypertension and related risk factors in Mexicans and MAs. The availability of these data resources should prove a stimulus for a new round of research on the evolving health status of this important population in the United States, and as a guide to directions for public health programs in Mexico to likewise reduce the substantial CVD burden in that country.
